These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31582326)

  • 21. Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
    Meringer H; Shibolet O; Deutsch L
    World J Gastroenterol; 2019 Aug; 25(29):3929-3940. PubMed ID: 31413528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changing trends in liver transplantation indications in Saudi Arabia: from hepatitis C virus infection to nonalcoholic fatty liver disease.
    Alqahtani SA; Broering DC; Alghamdi SA; Bzeizi KI; Alhusseini N; Alabbad SI; Albenmousa A; Alfaris N; Abaalkhail F; Al-Hamoudi WK
    BMC Gastroenterol; 2021 Jun; 21(1):245. PubMed ID: 34074270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States.
    Younossi ZM; Stepanova M; Ong J; Trimble G; AlQahtani S; Younossi I; Ahmed A; Racila A; Henry L
    Clin Gastroenterol Hepatol; 2021 Mar; 19(3):580-589.e5. PubMed ID: 32531342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indication for Liver Transplantation After Direct-Acting Agents in the Treatment of Patients With Hepatitis C.
    Arias ABV; Villegas Herrera MT; Arco Sánchez A; Adel ME; Triguero Cabrera J; Plata Illescas C; Montes Osuna MC; Santoyo Villalba J; Villar Del Moral JM
    Transplant Proc; 2022; 54(1):32-34. PubMed ID: 34911619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
    Cholankeril G; Wong RJ; Hu M; Perumpail RB; Yoo ER; Puri P; Younossi ZM; Harrison SA; Ahmed A
    Dig Dis Sci; 2017 Oct; 62(10):2915-2922. PubMed ID: 28744836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving survival in patients with hepatocellular carcinoma related to chronic hepatitis C and B but not in those related to non-alcoholic steatohepatitis or alcoholic liver disease: a 20-year experience from a national programme.
    Hassan I; Gane E
    Intern Med J; 2019 Nov; 49(11):1405-1411. PubMed ID: 30908822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocellular Carcinoma in the Setting of Chronic Hepatitis B Virus Infection: Tumor Recurrence and Survival Rates After Liver Transplantation.
    Dugum M; Hanouneh I; Lopez R; Aucejo F; Eghtesad B; Zein N
    Transplant Proc; 2015; 47(6):1939-44. PubMed ID: 26293077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction in Racial and Ethnic Disparity in Survival Following Liver Transplant for Hepatocellular Carcinoma in the Direct-acting Antiviral Era.
    Shaikh A; Goli K; Lee TH; Rich NE; Benhammou JN; Keeling S; Kim D; Ahmed A; Goss J; Rana A; Singal AG; Kanwal F; Cholankeril G
    Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2288-2297.e4. PubMed ID: 36521738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparable Survival for Hepatitis C-Related Hepatocellular Carcinoma After Liver Transplantation Irrespective of Viremic Status.
    Lymberopoulos P; Shaikh A; Rich NE; Benhammou JN; Kanwal F; Cholankeril G
    Clin Gastroenterol Hepatol; 2023 May; 21(5):1362-1364.e1. PubMed ID: 35346850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Future Trends in Demand for Liver Transplant: Birth Cohort Effects Among Patients With NASH and HCC.
    Shingina A; DeWitt PE; Dodge JL; Biggins SW; Gralla J; Sprague D; Bambha K
    Transplantation; 2019 Jan; 103(1):140-148. PubMed ID: 30451739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.
    Wong RJ; Cheung R; Ahmed A
    Hepatology; 2014 Jun; 59(6):2188-95. PubMed ID: 24375711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antivirals.
    Zanetto A; Shalaby S; Vitale A; Mescoli C; Ferrarese A; Gambato M; Franceschet E; Germani G; Senzolo M; Romano A; Angeli P; Rugge M; Farinati F; Forton DM; Cillo U; Burra P; Russo FP
    Liver Transpl; 2017 Sep; 23(9):1103-1112. PubMed ID: 28544587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Projected future increase in aging hepatitis C virus-infected liver transplant candidates: a potential effect of hepatocellular carcinoma.
    Biggins SW; Bambha KM; Terrault NA; Inadomi J; Shiboski S; Dodge JL; Gralla J; Rosen HR; Roberts JP
    Liver Transpl; 2012 Dec; 18(12):1471-8. PubMed ID: 23008049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.
    Younossi Z; Stepanova M; Ong JP; Jacobson IM; Bugianesi E; Duseja A; Eguchi Y; Wong VW; Negro F; Yilmaz Y; Romero-Gomez M; George J; Ahmed A; Wong R; Younossi I; Ziayee M; Afendy A;
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):748-755.e3. PubMed ID: 29908364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changing Trends of Cirrhotic and Noncirrhotic Hepatocellular Carcinoma in the Era of Directly-Acting Antiviral Agents.
    Mathur K; Mazhar A; Patel M; Dakhoul L; Burney H; Liu H; Nephew L; Chalasani N; deLemos A; Gawrieh S
    Clin Transl Gastroenterol; 2021 Nov; 12(11):e00420. PubMed ID: 34730559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing Population of Liver Transplant Recipients in the Era of Direct-acting Antiviral Therapy.
    Xie C; Kuo YF; Singal AK
    J Clin Transl Hepatol; 2020 Sep; 8(3):262-266. PubMed ID: 33083248
    [No Abstract]   [Full Text] [Related]  

  • 37. The future of liver transplantation for viral hepatitis.
    Durand F; Francoz C
    Liver Int; 2017 Jan; 37 Suppl 1():130-135. PubMed ID: 28052618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.
    Wong RJ; Aguilar M; Cheung R; Perumpail RB; Harrison SA; Younossi ZM; Ahmed A
    Gastroenterology; 2015 Mar; 148(3):547-55. PubMed ID: 25461851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States.
    Yang JD; Larson JJ; Watt KD; Allen AM; Wiesner RH; Gores GJ; Roberts LR; Heimbach JA; Leise MD
    Clin Gastroenterol Hepatol; 2017 May; 15(5):767-775.e3. PubMed ID: 28013117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Considerations When Treating Hepatitis C in a Cirrhotic Transplant Candidate.
    Daniel KE; Said A
    Curr Gastroenterol Rep; 2018 Apr; 20(5):20. PubMed ID: 29623506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.